FemTech Market Size, 2019-2027

The overall FemTech market size value accounted for $18.7B in 2019 and will reach $60B till 2027 with a CAGR of over 15.6%. Besides growing interest in recent years, the industry is still remaining underestimated and has a huge growth potential.
1500+ FemTech companies have been classified according to 14 subsectors and 8 aggregated subsectors by application. Accounting for 21.8% of the total market, Pregnancy is the largest subsector of the FemTech Industry. It is followed by Longevity and Fertility, which account for 13.1% each.

FemTech Companies Breakdown by Subsectors, 2021

Classifying the FemTech market by product types and analyzing the companies’ distribution, we see that Services is the largest category accounting for 34% of the entire FemTech market. The other products are more or less evenly distributed. Interestingly, 91% of the companies supply one product, while only 9% of them manufacture more than one product. The most popular combinations include Device and Service, App and Device, Femcare Product and Pharm Product.

Distribution of FemTech Companies by Product Type, 2021

Comprised of General Healthcare and Women’s Cancers Treatment (about 300 companies totally), Healthcare aggregated subsector receives the highest share of the total FemTech funding — 35.6%. Being the second largest aggregated subsector by the number of companies (384), Reproductive Health is also on the second place in terms of funding (20.3%). Longevity has 18.7% of the total industry funding, having about 200 companies. Despite having 88 companies, Personal Care & Wellbeing is one of the least funded aggregated subsectors. In terms of the funding status, Seed is the most popular type, followed by M&A and Early Stage Venture.

FemTech Aggregated Subsectors by Funding Amount, 2021

Of the six aggregated subsectors using AI, three account for 74% of all AI technologies used in FemTech. Being the second in terms of funding and by the number of companies, Reproductive Health has the highest number of companies using AI. Reproductive Health is followed by Healthcare and Beauty for FemTech, accounting for 24% and 21% respectively. Personal Care & Wellbeing aggregated subsector has the lowest number of companies using AI.

FemTech Aggregated Subsectors Share of AI Usage, 2021

Being an important part of the FemTech Industry, FemTech Longevity focuses on technologies, services, and research related to extending women’s healthy lifespan.

Geographically, the vast majority of companies in FemTech Longevity subsector are based in North America, particularly in the United States, where 58% of companies are located, and Canada at 4%. Europe is the second-largest region, with a 20% share, led by United Kingdom. Israel leads the Middle East region in the number of companies. Asian countries and Australia are somewhat less represented by FemTech Longevity subsector.

Distribution of FemTech Longevity Companies by Major Regions, 2021

Funding of companies in the FemTech Longevity subsector totaled over $3B in 2021, with 75% falling to the top 10 market players. In fact, 40% of funding was made through M&A, 28% from IPO, and 21% from VC.

Distribution of FemTech Longevity Companies by Funding Amount, 2021

In 2020, a total of $520M of VC capital was invested in FemTech, a slight decrease from 2019’s $592M. Nevertheless, overall VC investment in FemTech startups has grown tenfold since 2012.

Global VC Investments in FemTech, 2012-2020

FemTech investors mainly invest in Reproductive Health (25.8%). Healthcare and Longevity are the next largest aggregated subsectors in terms of investment (20.2% and 18.8% respectively). PharmTech has the lowest number of investors (1.1%). More than 40% of investors invest in multiple subsectors. 

Accounting for nearly 55%, North America, and more specifically, the US, is the leader in the number of FemTech investors. Europe is second at 25%, while Australia, Africa, and South America jointly account for only 2.8%. Despite having only 14% of FemTech investors, Asia can boast the largest share of Investment ($5.4B). There is a huge gap between investments in the top and bottom regions, such as Australia, Latin America, and Africa.

FemTech Investors Breakdown
by Aggregated Subsectors and Regions, 2021

With a total investment of $1.8 B, FemTech Investors mostly have 11-50 investments in their portfolios. At $4.5 B, investors with 51-100 investments have the highest value of investments. 71% of investors have fewer than 100 investments in their portfolios.

Distribution of Investors by the Number of Investments, 2021

In 2020, a total of $376.2 million was invested in FemTech startups. The interactive chart below represents 5 major deals in space.

Top-5 Investment Deals in FemTech in 2020

The interactive graph below depicts relationships between leading FemTech investors and companies they invested in. Majority of investors have high number of investments and value of funds, while all of them are heavily investing into FemTech. Nearly all investors are Venture Capitals, with minor exceptions for Micro VC, Angel group, and Accelerator.

Leading FemTech Investors Connections 

Having the highest share of Publicly Traded Companies, General Healthcare is followed by the Fertility, Women’s Cancers Treatment, and Beauty for FemTech subsectors. As can be seen in the diagram below, the number of companies does not entirely correlate with the funding amount. Pregnancy is funded relatively better, while Fertility and Sexual Healthcare get less funding.

Publicly Traded FemTech Companies Breakdown
by Regions and Subsectors, 2021

The interactive chart below illustrates 10 leading publicly traded companies in FemTech by the capitalization amount. Having the largest market capitalization at $4.75B and a big enough gap from the next player in the list, Progyny (Reproductive Health) is the Top publicly traded FemTech company.

Top 10 Publicly Traded Companies by Capitalization, 2021